Knott David M Jr Cti Biopharma Corp Transaction History

Knott David M Jr

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$4.2 - $6.01 $840 - $1,202	-200 Reduced 0.04%	566,487 $2.38 Million
Q2 2022 Aug 11, 2022	BUY	$3.55 - $6.27 $35,500 - $62,699	10,000 Added 1.8%	566,687 $3.38 Million
Q1 2022 May 16, 2022	BUY	$1.9 - $5.23 $637,655 - $1.76 Million	335,608 Added 151.8%	556,687 $2.6 Million
Q4 2021 Feb 11, 2022	BUY	$1.44 - $2.86 $318,353 - $632,285	221,079 New	221,079 $548,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.